Publications by authors named "Alberto Moriggia"

Claim this Profile
R
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs.
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, Margaret Hellard, Julie Bruneau, Alberto Moriggia

Clin Infect Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.
Andrea Bregenzer, Philip Bruggmann, Erika Castro, Alberto Moriggia, Madeleine Rothen

Swiss Med Wkly· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing?
Barbara Bertisch, Matteo Brezzi, Francesco Negro, Beat Müllhaupt, Cornelia Ottiger, Alberto Moriggia

Clin Infect Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030.
Nicolas Goossens, Stefano Bellentani, Andreas Cerny, Jean-Francois Dufour, François R Jornayvaz, Alberto Moriggia

Swiss Med Wkly· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users.
Salequl Islam, Damani A Piggott, Alberto Moriggia, Jacquie Astemborski, Shruti H Mehta

Harm Reduct J· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlling HCV in Switzerland: running against the clock.
Andreas Cerny, Raoul Blindenbacher, Alberto Moriggia

Swiss Med Wkly· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy.
Jason Grebely, Brian Conway, Evan B Cunningham, Chris Fraser, Alberto Moriggia

Int J Drug Policy· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations.
Barbara Bertisch, Fabio Giudici, Francesco Negro, Darius Moradpour, Beat Müllhaupt, Alberto Moriggia

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Alberto Moriggia, Felix Stickel

Ther Umsch· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in circulation of B and non-B HIV strains: spotlight on a reference centre for infectious diseases in Northern Italy.
Fausto Baldanti, Stefania Paolucci, Giovanni Ravasi, Anna Maccabruni, Alberto Moriggia

J Med Virol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis